Patent details

300880 Product Name: Snelwerkende insulin aspart

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300880
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2340033
Status:
Withdrawn
Application number:
300880
Procedural language:
Dutch
First Applicant Residence Country:
Denmark (DK)

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1160
Marketing Authorization Type:
EEA
Marketing Authorization Date:
11/01/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
16/06/2017
First Marketing Authorization date:
11/01/2017
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
22/06/2017
SPC/SPC Extension Expiration Date:
10/01/2032
Lapsed By Expiration Date:
Withdrawal date:
10/10/2017
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
16/06/2017
 
 

 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 BAGSVÆRD, Denmark (DK)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
16/06/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
43/17
Publication date:
25/10/2017
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
26/17
Publication date:
28/06/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
24/10/2017 Outgoing Correspondence Outgoing Letter 1 PDF /5/5/1/9/6/0800169155/docs/300880_11_outgoingcorrespondence20171025012542912.pdf
11/10/2017 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/5/1/9/6/0800169155/docs/300880_9_incomingcorrespondencepaper20171016012914691.pdf
22/06/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /5/5/1/9/6/0800169155/docs/300880_1_145720l174.pdf
16/06/2017 SPC Documents Accompanying letter SPC 2 PDF /5/5/1/9/6/0800169155/docs/300880_0_supplprotectioncertificate20170622085052102.pdf
16/06/2017 Application Form First filed application form 2 PDF /5/5/1/9/6/0800169155/docs/300880_2_applicationform20170622085051913.pdf
16/06/2017 SPC Documents Marketing Authorization SPC 4 PDF /5/5/1/9/6/0800169155/docs/300880_3_supplprotectioncertificate20170622085052504.pdf
16/06/2017 SPC Documents Certificate SPC 1 PDF /5/5/1/9/6/0800169155/docs/300880_4_supplprotectioncertificate20170622085052195.pdf
16/06/2017 SPC Documents Summary of the characteristics of the product 17 PDF /5/5/1/9/6/0800169155/docs/300880_5_supplprotectioncertificate20170622085052612.pdf
16/06/2017 SPC Documents Marketing Authorization SPC 3 PDF /5/5/1/9/6/0800169155/docs/300880_6_supplprotectioncertificate20170622085052302.pdf
16/06/2017 SPC Documents Annex SPC 66 PDF /5/5/1/9/6/0800169155/docs/300880_7_supplprotectioncertificate20170622085053056.pdf
16/06/2017 SPC Documents Annex SPC 2 PDF /5/5/1/9/6/0800169155/docs/300880_8_supplprotectioncertificate20170622085052874.pdf
16/06/2017 SPC Documents Subsequently filed documents 1 PDF /5/5/1/9/6/0800169155/docs/300880_10_supplprotectioncertificate20170622012737262.pdf